keyword
https://read.qxmd.com/read/38605688/polyposis-of-gastrointestinal-tract-after-covid-19-mrna-vaccination-a-report-of-two-cases
#1
Jun Ho Kim, Eun Hye Oh, Dong Soo Han
Cronkhite-Canada syndrome is a rare gastrointestinal polyposis syndrome with distinctive clinical features and endoscopic findings. Diagnosis can be challenging without suspicion, and the disease carries high mortality due to complications such as infection, gastrointestinal bleeding, and malignancies. This paper presents two cases of Cronkhite-Canada syndrome occurring after coronavirus disease 2019 (COVID-19) mRNA vaccination. Both cases exhibited typical clinical findings, including hypogeusia, onychodystrophy, alopecia, and weight loss...
April 12, 2024: Clinical Endoscopy
https://read.qxmd.com/read/38576936/navigating-the-complexity-of-churg-strauss-syndrome-presenting-as-acute-abdomen-a-comprehensive-review-and-case-report
#2
Subbarayudu Boda, Venkata Narayana Badipatla, Erramelli Nag Divya, Palak Dutta, Rohit Ganduboina
INTRODUCTION AND IMPORTANCE: Churg-Strauss syndrome (CSS) is a rare multisystemic condition characterized by asthma, blood and tissue eosinophilia, and vasculitis. The purpose of this work is to present a detailed overview of CSS, focusing on its epidemiology, clinical symptoms, histological criteria, gastrointestinal involvement, and therapy. CASE PRESENTATION: The authors report a case of a 40-year-old woman with CSS who had peripheral eosinophilia, small vessel vasculitis, and bronchial asthma...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38567382/adverse-effects-related-to-corticosteroid-use-in-sepsis-acute-respiratory-distress-syndrome-and-community-acquired-pneumonia-a-systematic-review-and-meta-analysis
#3
REVIEW
Dipayan Chaudhuri, Lori Israelian, Zbigniew Putowski, Jay Prakash, Tyler Pitre, Andrea M Nei, Joanna L Spencer-Segal, Hayley B Gershengorn, Djillali Annane, Stephen M Pastores, Bram Rochwerg
OBJECTIVES: We postulate that corticosteroid-related side effects in critically ill patients are similar across sepsis, acute respiratory distress syndrome (ARDS), and community-acquired pneumonia (CAP). By pooling data across all trials that have examined corticosteroids in these three acute conditions, we aim to examine the side effects of corticosteroid use in critical illness. DATA SOURCES: We performed a comprehensive search of MEDLINE, Embase, Centers for Disease Control and Prevention library of COVID research, CINAHL, and Cochrane center for trials...
April 2024: Critical care explorations
https://read.qxmd.com/read/38506343/prophylactic-corticosteroids-for-cardiopulmonary-bypass-in-adult-cardiac-surgery
#4
REVIEW
Riccardo Giuseppe Abbasciano, Guido Maria Olivieri, Rachel Chubsey, Francesca Gatta, Nathan Tyson, Keertana Easwarakumar, Daniel P Fudulu, Roberto Marsico, Markus Kofler, Ghazi Elshafie, Florence Lai, Mahmoud Loubani, Simon Kendall, Mustafa Zakkar, Gavin J Murphy
BACKGROUND: Cardiac surgery triggers a strong inflammatory reaction, which carries significant clinical consequences. Corticosteroids have been suggested as a potential perioperative strategy to reduce inflammation and help prevent postoperative complications. However, the safety and effectiveness of perioperative corticosteroid use in adult cardiac surgery is uncertain. This is an update of the 2011 review with 18 studies added. OBJECTIVES: Primary objective: to estimate the effects of prophylactic corticosteroid use in adults undergoing cardiac surgery with cardiopulmonary bypass on the: - co-primary endpoints of mortality, myocardial complications, and pulmonary complications; and - secondary outcomes including atrial fibrillation, infection, organ injury, known complications of steroid therapy, prolonged mechanical ventilation, prolonged postoperative stay, and cost-effectiveness...
March 20, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38432039/corticosteroid-in-non-covid-19-induced-community-acquired-pneumonia-a-meta-analysis
#5
JOURNAL ARTICLE
Jian Liu, Yongquan Dong, Jia Chen, Yuqing Jin, Yunqing Qiu, Lingtong Huang
BACKGROUND: Corticosteroid treatment in non-COVID-19 induced Community-acquired pneumonia (CAP) remains inconclusive. OBJECTIVES: We aimed to assess the role of corticosteroid treatment in CAP. METHODS: We conducted a comprehensive search of online databases, including PubMed, Embase, and Cochrane, to identify articles published from January 1, 2000, to May 5, 2023. Double-blind RCTs were selected. Two authors screened studies and extracted data...
March 2, 2024: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/38430143/the-complications-of-corticosteroid-for-patients-with-community-acquired-pneumonia-a-systematic-review-and-meta-analysis
#6
JOURNAL ARTICLE
Donglan Wang, Yan Zhu
BACKGROUND: Many randomized controlled trials (RCTs) have reported the complications of corticosteroids for patients with community-acquired pneumonia with inconsistent results. An explicit systematic review and meta-analysis were conducted in this study to evaluate the complications of corticosteroids for patients with community-acquired pneumonia. METHODS: Using PubMed, Embase, the Global Index Medicus of the World Health Organization (WHO), the WHO clinical trial registry, and Clinicaltrials...
March 1, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38399598/real-world-utilization-of-corticosteroids-in-severe-alcoholic-hepatitis-eligibility-response-and-outcomes
#7
JOURNAL ARTICLE
Ana-Maria Singeap, Horia Minea, Oana Petrea, Madalina-Andreea Robea, Ioana-Miruna Balmuș, Raluca Duta, Ovidiu-Dumitru Ilie, Carmen Diana Cimpoesu, Carol Stanciu, Anca Trifan
Background and Objectives: Alcoholic hepatitis (AH) poses a medical challenge, causing moderately severe to life-threatening episodes with high short- and long-term mortality. This study aimed to explore real-world corticosteroid utilization in severe AH, response predictors, and patient outcomes. Materials and Methods: We conducted a retrospective study on patients admitted for severe AH, defined as a Maddrey Discriminant Function score equal to or above 32, at a tertiary care center. We reviewed patients' medical observation charts to identify corticosteroid prescriptions, reasons for ineligibility, and response rates...
February 11, 2024: Medicina
https://read.qxmd.com/read/38362696/low-frequency-of-upper-gastrointestinal-bleeding-despite-non-steroidal-anti-inflammatory-drugs-and-corticosteroids-in-patients-with-rheumatoid-arthritis
#8
JOURNAL ARTICLE
Wilder Carvajal-Gutiérrez, María A Cisneros-Cisneros, Omar-Javier Calixto, Maria-Alejandra Meneses-Toro, Andrés Jesús Prada Rueda, Merardo A Vega-Báez, Duván A Álvarez-Vargas, Adriana C Uscátegui-Ruiz, Consuelo Romero-Sanchez, Juan-Manuel Bello-Gualtero
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease. It has been identified that non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can be essential risk factors for developing complications such as upper gastrointestinal bleeding (UGIB). OBJECTIVE: This study aimed to describe the safety profile of drugs used to treat RA focused in UGIB. METHODS: A cross-sectional study of patients with RA between 2015 and 2021, a description of the population, and an evaluation of the relationship with UGIB through bivariate analysis and logistic regression...
February 15, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38354995/comparing-the-efficacy-of-corticosteroids-among-patients-with-community-acquired-pneumonia-in-the-icu-versus-non-icu-settings-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Luis A Diaz Caballero, Ashnah Aijaz, Neha Saleem Paryani, Samar Mahmood, Madiha Salman, Mohammad Omer Khan, Dayal Ahluwalia, Mohammad Arham Siddiq, Ishaque Hameed
BACKGROUND: Despite the potential of corticosteroids in treating community-acquired pneumonia (CAP), conflicting evidence exists regarding their effect on mortality. To address this gap and provide new insights, we conducted a pre-specified subgroup meta-analysis of corticosteroid use in CAP patients, focusing on the ICU versus non-ICU subsets. METHODS: We searched PubMed, Cochrane Central Register of Controlled Trials and SCOPUS from inception to May 2023 for randomized controlled trials (RCTs)...
February 12, 2024: Steroids
https://read.qxmd.com/read/38336367/determining-the-optimal-treatment-target-in-patients-with-ulcerative-colitis-rationale-design-protocol-and-interim-analysis-for-the-randomised-controlled-verdict-trial
#10
JOURNAL ARTICLE
Vipul Jairath, Guangyong Zou, Zhongya Wang, Shashi Adsul, Jean-Frederic Colombel, Geert R D'Haens, Marcelo Freire, Gordon W Moran, Laurent Peyrin-Biroulet, William J Sandborn, Shaji Sebastian, Simon Travis, Séverine Vermeire, Gabriela Radulescu, Julie Sigler, Jurij Hanžel, Christopher Ma, Rocio Sedano, Stefanie C McFarlane, Naveen Arya, Melanie Beaton, Peter Bossuyt, Silvio Danese, Daniel Green, William Harlan, Marek Horynski, Maria Klopocka, Rima Petroniene, Mark S Silverberg, Lukasz Wolanski, Brian G Feagan
INTRODUCTION: Symptoms, endoscopy and histology have been proposed as therapeutic targets in ulcerative colitis (UC). Observational studies suggest that the achievement of histologic remission may be associated with a lower risk of complications, compared with the achievement of endoscopic remission alone. The actiVE ulcerative colitis, a RanDomIsed Controlled Trial (VERDICT) aims to determine the optimal treatment target in patients with UC. METHODS AND ANALYSIS: In this multicentre, prospective randomised study, 660 patients with moderate to severe UC (Mayo rectal bleeding subscore [RBS] ≥1; Mayo endoscopic score [MES] ≥2) are randomly assigned to three treatment targets: corticosteroid-free symptomatic remission (Mayo RBS=0) (group 1); corticosteroid-free endoscopic remission (MES ≤1) and symptomatic remission (group 2); or corticosteroid-free histologic remission (Geboes score <2B...
February 8, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38298173/in-situ-piezoelectric-catalytic-anti-inflammation-promotes-the-rehabilitation-of-acute-spinal-cord-injury-in-synergy
#11
JOURNAL ARTICLE
Yanling You, Junjie Jiang, Gang Zheng, Zhixin Chen, Ya-Xuan Zhu, Hongshi Ma, Han Lin, Xiang Guo, Jianlin Shi
Relieving inflammation via scavenging toxic reactive oxygen species (ROS) during the acute phase of spinal cord injury (SCI) has been proved to be an effective strategy to mitigate secondary spinal cord injury and improve recovery of motor function. However, commonly used corticosteroid anti-inflammatory drugs such as methylprednisolone show adverse side effects which may induce gastrointestinal bleeding, femoral head necrosis and an increased risk of wound infection. Fortunately, hydrogen (H2 ), featuring selective antioxidant performance, easy penetrability and excellent biosafety, is being extensively investigated as a potential anti-inflammatory therapeutic gas for the treatment of SCI...
February 1, 2024: Advanced Materials
https://read.qxmd.com/read/38262670/impact-of-different-corticosteroids-on-severe-community-acquired-pneumonia-a-systematic-review-and-meta-analysis
#12
JOURNAL ARTICLE
Xin Ya See, Tsu Hsien Wang, Yu-Cheng Chang, Juien Lo, Weitao Liu, Cheryn Yu Wei Choo, Yu-Che Lee, Kevin Sheng Kai Ma, Cho-Hsien Chiang, Yuan Ping Hsia, Cho-Hung Chiang, Cho-Han Chiang
OBJECTIVES: Randomised controlled trials (RCTs) have demonstrated conflicting results regarding the effects of corticosteroids on the treatment of severe community-acquired pneumonia (CAP). We aimed to investigate the efficacy and safety of different corticosteroids on patients who were hospitalised for severe CAP. METHODS: We performed a systematic search through PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus from inception to May 2023...
January 22, 2024: BMJ Open Respiratory Research
https://read.qxmd.com/read/38202069/clinical-dilemma-involving-treatments-for-very-low-birth-weight-infants-and-the-potential-risk-of-necrotizing-enterocolitis-a-narrative-literature-review
#13
REVIEW
Shigeo Iijima
Necrotizing enterocolitis (NEC) is a critical gastrointestinal emergency with substantial morbidity and mortality risks, especially for very low-birth-weight (VLBW) infants, and unclear multifactorial pathophysiology. Whether common treatments for VLBW infants increase the NEC risk remains controversial. Indomethacin (utilized for patent ductus arteriosus) offers benefits but is concerning because of its vasoconstrictive impact on NEC susceptibility. Similarly, corticosteroids used to treat bronchopulmonary dysplasia may increase vulnerability to NEC by compromising immunity and altering the mesenteric blood flow...
December 22, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38156834/efficacy-and-safety-of-ibrutinib-for-chronic-graft-versus-host-disease-a-systematic-review
#14
JOURNAL ARTICLE
Damai Santosa, Daniel Rizky, Kevin Tandarto, Ika Kartiyani, Vina Yunarvika, Desta Nur Ewika Ardini, Budi Setiawan, Eko Adhi Pangarsa, Catharina Suharti
INTRODUCTION: Allogeneic hematopoietic cell transplantation (allo-HCT) serves as a potentially curative intervention for various hematologic disorders. However, its utility can be limited by the emergence of chronic graft-versus-host disease (cGVHD). The clinical manifestations of cGVHD result from a complex immune response characterized by the involvement of both B and T cells. Ibrutinib, a pharmacological agent, acts as an inhibitor of Bruton's tyrosine kinase (BTK) pathway, which becomes activated through the B-cell receptor and regulates B-cell survival...
December 1, 2023: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38143678/pulmonary-embolization-after-gastric-varices-obliteration
#15
Mafalda Duarte, Marta Lopes, Martim Trovão Bastos, Ana Monteiro, Rodrigo Duarte
N-butyl-2-cyanoacrylate (NB2CYA) is frequently used in the treatment of variceal hemorrhage with a success rate in hemostatic control of 87%-100%. Although rare, complications include esophageal perforation, infection, or arterial and venous embolization. We present the case of a 67-year-old male with chronic ethanolic liver disease hospitalized due to melena and hematemesis. He had anemia requiring transfusion support, octreotide, and pantoprazole infusion. Upper digestive endoscopy was performed showing gastric varices with a hemorrhagic rupture point treated with cyanoacrylate...
November 2023: Curēus
https://read.qxmd.com/read/38130789/hemophagocytic-lymphohistiocytosis-with-jaundice-as-first-manifestation-a-case-report
#16
Dan-Dan Wang, Sheng Wu, Bing-Bing Kong, Lin-Lin Song
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare but life-threatening condition. It is an immune-mediated disease that has a wide range of causes, elicits a hyperinflammatory response, and results in multiple organ damage. Clinical presentations vary, and in some cases, jaundice occurs as the first symptom. CASE SUMMARY: We report the case of a 71-year-old female patient who presented with jaundice. She was admitted to our hospital because of the occurrence of "jaundice for half a month", and upon examination, obstructive jaundice with choledocholithiasis and gallstones was suggested...
December 6, 2023: World Journal of Clinical Cases
https://read.qxmd.com/read/38089867/extracorporeal-membrane-oxygenation-treatment-for-severe-asthma-had-unexpected-adverse-effects-a-case-report
#17
Yun Wang, Weimin Zhang, Xingxing Chen, Xuping Cheng, Xuandong Jiang
Asthma, a chronic respiratory ailment, affects millions worldwide. Extracorporeal membrane oxygenation (ECMO) has gained traction as a life-saving intervention for patients with severe asthma who are unresponsive to conventional treatments. However, complications associated with ECMO, including electrolyte imbalances and hemorrhage, can have significant clinical implications. This case report highlights a 49 years-old male patient with severe asthma who developed pronounced hypokalemia and hemorrhage following venovenous ECMO (VVECMO) therapy...
2023: Frontiers in Medicine
https://read.qxmd.com/read/38011683/granulocyte-colony-stimulating-factor-plus-pentoxifylline-increases-short-term-survival-in-patients-with-severe-alcoholic-hepatitis-a-network-meta-analysis
#18
REVIEW
Fangfang Duan, Chen Liu, Chunyan Chang, Shanshan Song, Hang Zhai, Jun Cheng, Song Yang
Background: Optimal treatments for severe alcoholic hepatitis (SAH) remain controversial. Previous network meta-analysis showed that corticosteroid (CS) combined with N-acetylcysteine (NAC) was superior in reducing short-term mortality of patients with SAH. Recently, granulocyte colony-stimulating factor (G-CSF) treatments for SAH yielded promising results. Objectives: To determine how currently available treatments affect the survival and complications of patients with SAH. Methods: The study was conducted following the guidelines of PRISMA...
November 27, 2023: American Journal of Drug and Alcohol Abuse
https://read.qxmd.com/read/37986286/varicella-associated-disseminated-intravascular-coagulation-secondary-to-henoch-sch%C3%A3-nlein-purpura-with-renal-and-gastrointestinal-system-involvement-in-a-child-a-case-report
#19
JOURNAL ARTICLE
Jing Jiang, Kai Liao, Hui Guo, Xiu-Ying Chen
RATIONALE: Immunocompromised patients who developed varicella-zoster virus (VZV)-associated disseminated intravascular coagulation (DIC) previously included recipients of bone marrow, hematopoietic stem cell, or organ transplantations, patients with primary nephropathy receiving corticosteroid therapy, cancer patients receiving chemotherapy, and patients with human immune deficiency virus infection. The case reported here is novel because, to our knowledge, there has been no report of VZV-associated DIC after the onset of Henoch-Schönlein purpura (HSP)...
November 17, 2023: Medicine (Baltimore)
https://read.qxmd.com/read/37930588/pharmacodynamic-drug-drug-interactions-and-bleeding-outcomes-in-patients-with-atrial-fibrillation-using-non-vitamin-k-antagonist-oral-anticoagulants-a-nationwide-cohort-study
#20
JOURNAL ARTICLE
Maxim Grymonprez, Andreas Capiau, Stephane Steurbaut, Koen Boussery, Els Mehuys, Annemie Somers, Mirko Petrovic, Tine L De Backer, Lies Lahousse
PURPOSE: Pharmacodynamic drug-drug interactions (PD DDIs) may influence the safety of non-vitamin K antagonist oral anticoagulants (NOACs), but the extent to which PD DDIs increase bleeding risks, remains unclear. Therefore, the impact of PD DDIs on bleeding outcomes in NOAC-treated patients with atrial fibrillation (AF) was investigated. METHODS: Using Belgian nationwide data, NOAC-treated AF patients were included between 2013-2019. Concomitant use of PD interacting drugs when initiating NOAC treatment was identified...
November 6, 2023: Cardiovascular Drugs and Therapy
keyword
keyword
28389
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.